Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Aug;62(2):255–256. doi: 10.1038/bjc.1990.271

Relationship between chemoresistance of lung tumours and cigarette smoking.

M Volm 1, B Samsel 1, J Mattern 1
PMCID: PMC1971821  PMID: 2167122

Full text

PDF
256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auner H., Petru E., Hofmann H. M., Pickel H., Pürstner P. In vitro chemosensitivity testing in the treatment of ovarian carcinoma. Arch Gynecol Obstet. 1989;246(4):227–231. doi: 10.1007/BF00934523. [DOI] [PubMed] [Google Scholar]
  2. Burt R. K., Garfield S., Johnson K., Thorgeirsson S. S. Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis. 1988 Dec;9(12):2329–2332. doi: 10.1093/carcin/9.12.2329. [DOI] [PubMed] [Google Scholar]
  3. Burt R. K., Thorgeirsson S. S. Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. J Natl Cancer Inst. 1988 Nov 2;80(17):1383–1386. doi: 10.1093/jnci/80.17.1383. [DOI] [PubMed] [Google Scholar]
  4. Carmichael J., Mitchell J. B., Friedman N., Gazdar A. F., Russo A. Glutathione and related enzyme activity in human lung cancer cell lines. Br J Cancer. 1988 Oct;58(4):437–440. doi: 10.1038/bjc.1988.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carr B. I. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats. Cancer Res. 1987 Nov 1;47(21):5577–5583. [PubMed] [Google Scholar]
  6. Fairchild C. R., Ivy S. P., Rushmore T., Lee G., Koo P., Goldsmith M. E., Myers C. E., Farber E., Cowan K. H. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7701–7705. doi: 10.1073/pnas.84.21.7701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gottesman M. M. Multidrug resistance during chemical carcinogenesis: a mechanism revealed? J Natl Cancer Inst. 1988 Nov 2;80(17):1352–1353. doi: 10.1093/jnci/80.17.1352. [DOI] [PubMed] [Google Scholar]
  8. Khoo S. K., Hurst T., Webb M. J., Dickie G., Kearsley J., Parsons P. G., Mackay E. V. Clinical value of in vitro drug sensitivity testing based on short-term effects on DNA and RNA metabolism in ovarian cancer. J Surg Oncol. 1989 Jul;41(3):201–205. doi: 10.1002/jso.2930410314. [DOI] [PubMed] [Google Scholar]
  9. Lai S. L., Goldstein L. J., Gottesman M. M., Pastan I., Tsai C. M., Johnson B. E., Mulshine J. L., Ihde D. C., Kayser K., Gazdar A. F. MDR1 gene expression in lung cancer. J Natl Cancer Inst. 1989 Aug 2;81(15):1144–1150. doi: 10.1093/jnci/81.15.1144. [DOI] [PubMed] [Google Scholar]
  10. Radosevich J. A., Robinson P. G., Rittmann-Grauer L. S., Wilson B., Leung J. P., Maminta M. L., Warren W., Rosen S. T., Gould V. E. Immunohistochemical analysis of pulmonary and pleural tumors with the monoclonal antibody HYB-612 directed against the multidrug resistance (MDR-1) gene product, P-glycoprotein. Tumour Biol. 1989;10(5):252–257. doi: 10.1159/000217622. [DOI] [PubMed] [Google Scholar]
  11. Thorgeirsson S. S., Huber B. E., Sorrell S., Fojo A., Pastan I., Gottesman M. M. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science. 1987 May 29;236(4805):1120–1122. doi: 10.1126/science.3576227. [DOI] [PubMed] [Google Scholar]
  12. Volm M., Brüggemann A., Günther M., Kleine W., Pfleiderer A., Vogt-Schaden M. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Cancer Res. 1985 Oct;45(10):5180–5185. [PubMed] [Google Scholar]
  13. Volm M., Drings P., Hahn E. W., Mattern J. Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test. Br J Cancer. 1988 Feb;57(2):198–200. doi: 10.1038/bjc.1988.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Volm M., Drings P., Mattern J., Sonka J., Vogt-Moykopf I., Wayss K. Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer. 1985 Sep 15;56(6):1396–1403. doi: 10.1002/1097-0142(19850915)56:6<1396::aid-cncr2820560630>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  15. Volm M., Efferth T., Bak M., Ho A. D., Mattern J. Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method. Eur J Cancer Clin Oncol. 1989 Apr;25(4):743–749. doi: 10.1016/0277-5379(89)90213-7. [DOI] [PubMed] [Google Scholar]
  16. Volm M., Wayss K., Kaufmann M., Mattern J. Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer. 1979 Jul;15(7):983–993. doi: 10.1016/0014-2964(79)90282-2. [DOI] [PubMed] [Google Scholar]
  17. Zijlstra J. G., de Vries E. G., Mulder N. H. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 1987 Apr 1;47(7):1780–1784. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES